Peter N. van Harten

2.5k citations

53 papers · 1.6k indexed · h-index 26

Psychiatry and Mental health top 1%
- Schizophrenia research and treatment 39
- Bipolar Disorder and Treatment 9
- Psychosomatic Disorders and Their Treatments 5
Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 13
- Neurological disorders and treatments 12
- Botulinum Toxin and Related Neurological Disorders 5
- Parkinson's Disease and Spinal Disorders 4
Biological Psychiatry top 10%
Cellular and Molecular Neuroscience top 10%
Cognitive Neuroscience top 10%
Clinical Psychology
- Obsessive-Compulsive Spectrum Disorders 5

Co-authors: Jim van Os Diederik E. Tenback P. Roberto Bakker Glenn E. Matroos Hans W. Hoek René S. Kahn Jan K. Buitelaar C. J. Slooff
Cited by: Psychiatry and Mental health Neurology Biological Psychiatry
Journals: American Journal of Psychiatry (2 papers)Neuroscience & Biobehavioral Reviews (2 papers)The British Journal of Psychiatry (1 paper)
Partner nations: Netherlands United States Curacao

In The Last Decade

Peter N. van Harten

52 papers receiving 1.5k citations

Peers

Countries citing papers authored by Peter N. van Harten

Since Specialization

Citations

This map shows the geographic impact of Peter N. van Harten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter N. van Harten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter N. van Harten more than expected).

Fields of papers citing papers by Peter N. van Harten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter N. van Harten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter N. van Harten. The network helps show where Peter N. van Harten may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter N. van Harten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter N. van Harten Line = papers co-authored together Peter N. van Harten links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Results on side effects Schizophrenia Research ·Mushde Shakir,Peter N. van Harten,Adriaan W. Hoogendoorn,Anne Willems,Diederik E. Tenback	2024	0
2	The effect on relapse rate and psychiatric symptomatology: Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. A pragmatic randomized open-label trial (SwAP trial) Schizophrenia Research ·Mushde Shakir,Anne E. Willems,Peter N. van Harten,Remko van Lutterveld,Diederik E. Tenback	2022	6
3	Proxy WHO Disability Assessment Schedule 2.0 Is Clinically Useful for Assessing Psychosocial Functioning in Severe Mental Illness Frontiers in Psychiatry ·Anne B. Koopmans,Daphne van Hoeken,Diana E. Clarke,David J. Vinkers,Peter N. van Harten,Hans W. Hoek	2020	12
4	The clinical and prognostic value of motor abnormalities in psychosis, and the importance of instrumental assessment Neuroscience & Biobehavioral Reviews ·Peter N. van Harten,Sebastian Walther,Jerillyn S. Kent,Scott R. Sponheim,Vijay A. Mittal	2017	78
5	Instrumental measurements of spontaneous dyskinesia and schizotypy in subjects with auditory verbal hallucinations and healthy controls Psychiatry Research ·Anne E. Willems,Iris E. Sommer,Diederik E. Tenback,Jeroen Koning,Peter N. van Harten	2016	8
6	The effect of the Taq1A variant in the dopamine D2 receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys Pharmacogenetics and Genomics ·Yvette Roke,Peter N. van Harten,Barbara Franke,Tessel E. Galesloot,Annemieke M. Boot,Jan K. Buitelaar	2013	30
7	Risk of Hyperprolactinemia and Sexual Side Effects in Males 10–20 Years Old Diagnosed with Autism Spectrum Disorders or Disruptive Behavior Disorder and Treated with Risperidone Journal of Child and Adolescent Psychopharmacology ·Yvette Roke,Jan K. Buitelaar,Annemieke M. Boot,Diederik E. Tenback,Peter N. van Harten	2012	36
8	Efficacy and Safety of Deep Brain Stimulation in Patients With Medication-Induced Tardive Dyskinesia and/or Dystonia The Journal of Clinical Psychiatry ·Charlotte L. Mentzel,Diederik E. Tenback,Marina A.J. Tijssen,Veerle Visser‐Vandewalle,Peter N. van Harten	2012	39
9	Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment European Journal of Endocrinology ·Yvette Roke,Peter N. van Harten,Jan K. Buitelaar,Diederik E. Tenback,Lorentz G.B.A. Quekel,Yolanda B. de Rijke,Annemieke M. Boot	2012	25
10	Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients Psychopharmacology ·(unknown),Jeroen Koning,Jelle Vehof,Huibert Burger,Bob Wilffert,Asmar Al Hadithy,Behrooz Z. Alizadeh,Peter N. van Harten,Harold Snieder	2011	32
11	Non‐therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: A meta‐analysis Movement Disorders ·Diederik E. Tenback,Peter N. van Harten,Jim van Os	2009	53
12	Dyskinesia and Parkinsonism in Antipsychotic-Naive Patients With Schizophrenia, First-Degree Relatives and Healthy Controls: A Meta-analysis Schizophrenia Bulletin ·Jeroen Koning,Diederik E. Tenback,Jim van Os,André Alemán,R.S. Kahn,Peter N. van Harten	2008	95
13	Evidence that lithium protects against tardive dyskinesia: The Curaçao Extrapyramidal Syndromes study VI European Neuropsychopharmacology ·Peter N. van Harten,Hans W. Hoek,Glenn E. Matroos,Jim van Os	2007	15
14	Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study Comprehensive Psychiatry ·Diederik E. Tenback,Peter N. van Harten,C. J. Slooff,Jim van Os	2007	23
15	Botulinum toxin in the treatment of orofacial tardive dyskinesia: A single blind study Progress in Neuro-Psychopharmacology and Biological Psychiatry ·Christina W. Slotema,Peter N. van Harten,Richard Bruggeman,Hans W. Hoek	2007	20
16	The course of tardive dystonia in Afro Caribbean patients, a population-based study Schizophrenia Research ·Peter N. van Harten,Glenn E. Matroos,Jim van Os	2007	10
17	Tardive Dyskinesia in Schizophrenia is Associated with Prolactin-Related Sexual Disturbances Neuropsychopharmacology ·(unknown),Diederik E. Tenback,Peter N. van Harten,C. J. Slooff,Jim van Os	2006	16
18	Incidence of Tardive Dyskinesia and Tardive Dystonia in African Caribbean Patients on Long-Term Antipsychotic Treatment The Journal of Clinical Psychiatry ·Peter N. van Harten,Hans W. Hoek,Glenn E. Matroos,Jim van Os	2006	25
19	Tardive Dystonia Schizophrenia Bulletin ·Peter N. van Harten,R. S. Kahn	1999	40
20	Intermittent Neuroleptic Treatment and Risk for Tardive Dyskinesia: Curaçao Extrapyramidal Syndromes Study III American Journal of Psychiatry ·Peter N. van Harten,Hans W. Hoek,Glenn E. Matroos,Maarten W.J. Koeter,René S. Kahn	1998	49

About Peter N. van Harten

Peter N. van Harten is a scholar working on Psychiatry and Mental health, Neurology and Clinical Psychology, having authored 53 papers that have together received 1.6k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (39 papers), Parkinson's Disease Mechanisms and Treatments (13 papers), Neurological disorders and treatments (12 papers), Bipolar Disorder and Treatment (9 papers), Obsessive-Compulsive Spectrum Disorders (5 papers), Psychosomatic Disorders and Their Treatments (5 papers), Botulinum Toxin and Related Neurological Disorders (5 papers) and Parkinson's Disease and Spinal Disorders (4 papers). The work is most often cited by research in Psychiatry and Mental health (1.1k citations), Neurology (657 citations) and Biological Psychiatry (51 citations). Peter N. van Harten has collaborated with scholars based in Netherlands, United States and Curacao. Frequent co-authors include Jim van Os, Diederik E. Tenback, P. Roberto Bakker, Glenn E. Matroos, Hans W. Hoek, René S. Kahn, Jan K. Buitelaar, C. J. Slooff, Annemieke M. Boot and Sebastian Walther. Their work appears in journals such as American Journal of Psychiatry, Neuroscience & Biobehavioral Reviews and The British Journal of Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact